JMS-053

CAT: 0804-HY-135457-01Size: 1 mgDry Ice: NoHazardous: No
CAT#:0804-HY-135457-01Size:1 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
JMS-053 is an efficient and reversible PTP4A3 inhibitor, with an IC50 value of 18 nM. JMS-053 demonstrates broad PTP4A inhibitory activity with IC50s of 50 nM and 53 nM for PTP4A1 and PTP4A2, respectively. JMS-053 exhibits IC50 values of 92.6 nM and 207.6 nM for CDC25B and DUSP3, respectively. JMS-053 can effectively inhibit the activity of PTP4A3, inhibit tumor cell proliferation and migration through multiple mechanisms such as interfering with RhoA and STAT3/p38 signaling pathway. JMS-053 can be used for the study of cancers such as ovarian cancer, breast cancer and colon cancer[1][2][3][4][5].
CAS Number
[1954650-11-3]
UNSPSC
12352005
Target
Phosphatase; Ras; STAT
Type
Reference compound
Related Pathways
GPCR/G Protein; JAK/STAT Signaling; MAPK/ERK Pathway; Metabolic Enzyme/Protease; Stem Cell/Wnt
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/jms-053.html
Purity
98.0
Solubility
DMSO : 10 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C1C(C=C(C2=CC=CC=C2)S3)=C3C(C(N1)=O)=N
Molecular Formula
C13H8N2O2S
Molecular Weight
256.28
References & Citations
[1]Lazo JS, et, al. Next-Generation Cell-Active Inhibitors of the Undrugged Oncogenic PTP4A3 Phosphatase. J Pharmacol Exp Ther. 2019 Dec;371 (3) :652-662.|[2]McQueeney KE, et al. Targeting ovarian cancer and endothelium with an allosteric PTP4A3 phosphatase inhibitor. Oncotarget. 2017 Dec 30;9 (9) :8223-8240.|[3]Rastelli EJ, et al. Synthesis and evaluation of bifunctional PTP4A3 phosphatase inhibitors activating the ER stress pathway. Bioorg Med Chem Lett. 2021 Aug 15;46:128167. |[4]Lazo JS, Isbell KN, Vasa SA, Llaneza DC, Rastelli EJ, Wipf P, Sharlow ER. Disruption of Ovarian Cancer STAT3 and p38 Signaling with a Small-Molecule Inhibitor of PTP4A3 Phosphatase. J Pharmacol Exp Ther. 2023 Mar;384 (3) :429-438. doi: 10.1124/jpet.122.001401. Epub 2023 Jan 10. PMID: 36627205; PMCID: PMC9976793.|[5]McQueeney KE, et al. A chemical genetics approach identifies PTP4A3 as a regulator of colon cancer cell adhesion. FASEB J. 2018 Oct;32 (10) :5661-5673. doi: 10.1096/fj.201701446R. Epub 2018 May 10. PMID: 29746167; PMCID: PMC6133700.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
STAT3

Related Products

CatalogName
HY-P991356FAZ-053
HY-123918-01JMS-17-2
HY-149359IHMT-IDH1-053
HY-168219-01JMS-175-2
HY-123918AJMS-17-2 (hydrochloride)
HY-101268CHMFL-ABL-053
HY-103078-01I-XW-053
HY-123426JY-XHe-053
HY-103078AI-XW-053 (sodium)
HY-115857SH-053-S-CH3-2'F

Alternative Products

CatalogName
M35412-01JMS-053
MBS5814244JMS-038
MF-0100809-01FAZ-053
MBS3601574-01JMS-17-2
MBS5777407JY-XHe-053
MF-0051246-01CHMFL-ABL-053
MF-0156826-01IHMT-IDH1-053
MF-0142711-01JMS-175-2
A19100-25JMS-17-2 25mg
MF-0018416-01I-XW-053

Popular Products